Dr. Shuldiner received his undergraduate degree in chemistry from Lafayette College, and his medical degree from Harvard Medical School. He completed residency training in internal medicine at Columbia Presbyterian Hospital, and his postdoctoral fellowship in Endocrinology and Metabolism in the Diabetes Branch at the National Institutes of Health. Dr. Shuldiner served on the faculty at Johns Hopkins University in Baltimore and at the University of Maryland School of Medicine where he was the John Whitehurst Endowed Professor of Medicine, and served as Associate Dean and founding director of the Program for Genetics and Genomic Medicine, and Head of the Division of Endocrinology, Diabetes and Nutrition.
Dr. Shuldiner’s major research interests lie in the molecular biology and genetics age-related diseases including of diabetes, obesity, osteoporosis, and cardiovascular disease, common disorders that contribute significantly to mortality, morbidity, and functional loss. He also works on the pharmaco- and nutri-genomics of these disorders. He is best known for his research in the Old Order Amish, a homogeneous founder population ideal for genetic studies. Dr. Shuldiner has authored more than 400 original articles in leading journals and 70 reviews and book chapters. He is the recipient of a number of awards including the prestigious Paul Beeson Physician Faculty Scholar award, Ellison Medical Foundation Senior Scholar award, University of Maryland Founders Day Researcher of the Year award, and Grant R.Wilkinson Distinguished Lectureship.
In September 2014, Dr. Shuldiner became Vice President of the Regeneron Genetics Center where he continues to work in discovery and translational genomics, applying high-throughput sequencing and analytical approaches to glean insights into human biology and to identify and validate novel drug targets for diseases of unmet need. He founded the DRIFT Program, which focuses on special and founder population genetic discovery and clinical translation.